Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

View:
Post by kalman007 on Apr 18, 2022 9:56am

DISGUSTING

This company disgusts me.  Sorry to vent but I detect a hint of being deceived by management as to the true status of PMN310 and others.  It was a long shot years ago but their promises and road map to clinicals in hindsight was total BS!!!!!!!!!!
Comment by goldtech on Apr 18, 2022 12:05pm
This management team filled their pockets and lied from day one. Creating shareholder equity was a ruse so they could get free shares and paid too much. Look at this bunch, a geriatric Director that does nothing, a Canadian lawyer who knows nothing, a greedy duo of lying Directors and always saying a partnership is imminent. They only know how to dilute our interests and talk lots Pathetic it is!! ...more  
Comment by azzymaa on Apr 18, 2022 12:36pm
I cashed out at .125 and broke even. There are people like m101 here that are pumping the stock and lying. 
Comment by M101 on Apr 18, 2022 12:53pm
The roadmap turned out wrong because the consultants couldn't execute, but did they ever believe it?  I think they did for a couple of years, before it became obvious that they lacked the industry pull for any quick corporate deals.  They got their initial loans back in short order so they were never big believers, and when they structured more for consulting fees than options that ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities